Melanocytic naevi of other and unspecified parts of face

DOID MESH PheWeb

CD2_BENIGN_MELANOCYTIC_FACE

No definition available.

Endpoint definition

↥

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D22.3&

Hospital discharge: ICD-9 2163A

Cause of death: ICD-10 D22.3&

Cause of death: ICD-9 2163A

2 out of 7 registries used, show all original rules.

1626

diagram downward connector

Check minimum number of events None

1626

diagram downward connector

Include endpoints None

1626

diagram downward connector

diagram downward connector

Remove individuals based on genotype QC

1574

diagram downward connector

CD2_BENIGN_MELANOCYTIC_FACE

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF2

Parent code in ICD-10 D22

Name in latin Naevus melanocyticus (cutis) faciei

NAME	CD2_BENIGN_MELANOCYTIC_FACE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D223
HD_ICD_9	2163A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D223
COD_ICD_9	2163A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Show upset plot detailing case counts by codes

Or the full data table

Similar endpoints

↥

List of similar endpoints to Melanocytic naevi of other and unspecified parts of face based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Melanocytic naevi of other and unspecified parts of face (controls excluding all cancers)

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	1574	1098	476
Unadjusted prevalence (%)	0.42	0.52	0.29
Mean age at first event (years)	48.56	46.16	54.11

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.02	1.03 [0.46, 2.30]	9.4e-1	83
15 years	0.00	0.77 [0.36, 1.65]	5.0e-1	45
5 years	0.00	1.34 [0.65, 2.73]	4.2e-1	20
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_BENIGN_MELANOCYTIC_FACE – Melanocytic naevi of other and unspecified parts of face
GWS hits: 1

Survival analyses between endpoints

↥

Plot

before Melanocytic naevi of other and unspecified parts of face
after Melanocytic naevi of other and unspecified parts of face

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Melanocytic naevi of other and unspecified parts of face

↥

Endpoint not on priority list, no data to show.